Correlation Engine 2.0
Clear Search sequence regions


  • AMKL (4)
  • anti- igg (1)
  • antibodies (1)
  • avidin (1)
  • birth (2)
  • blood (1)
  • blue (1)
  • cases (3)
  • CD235a (1)
  • CD71 (1)
  • cdna (1)
  • cell extracts (1)
  • cells growth (1)
  • children (1)
  • chromatin (11)
  • chronic leukemia (1)
  • CMK (4)
  • CTCF (4)
  • cytokines (1)
  • diamond- blackfan anemia (1)
  • displaces (1)
  • dna repair (1)
  • dna sequences (2)
  • E2F1 (1)
  • edta (1)
  • element (1)
  • eosinophils (1)
  • erythroblast (1)
  • erythroid cells (1)
  • essential (4)
  • ethanol (1)
  • exon (12)
  • experiments human (1)
  • factor (8)
  • fast (2)
  • GATA (19)
  • gata factors (2)
  • Gata2 (4)
  • gene (38)
  • HBG1 (2)
  • human (4)
  • intron (1)
  • ips cells (1)
  • japan (1)
  • KLF1 (2)
  • kod (1)
  • leukemia (1)
  • light (1)
  • liver (2)
  • m 280 (1)
  • mass (1)
  • mast cells (1)
  • model experiments (1)
  • mrna (4)
  • MYC (4)
  • myeloid leukemia (20)
  • myelopoiesis (30)
  • neonates (1)
  • new england (3)
  • newborns (1)
  • noise (2)
  • nu7441 (1)
  • numbers cells (1)
  • oligos (1)
  • pathogenesis (1)
  • patients (3)
  • pcr (19)
  • PDGFRA (1)
  • period (1)
  • pGL4 (1)
  • phenol (1)
  • plasmid (1)
  • POLR2A (1)
  • profiles (5)
  • project (1)
  • promega (2)
  • protein dna complexes (1)
  • Protein G (1)
  • protein levels (1)
  • protein- complexes (1)
  • protocol (2)
  • reagent (1)
  • receptor (1)
  • regulates (3)
  • renilla (1)
  • repress (1)
  • rnas (16)
  • SCF (6)
  • seq (23)
  • serum (1)
  • signals (3)
  • sirnas (4)
  • size samples (1)
  • sodium (1)
  • stem (1)
  • stem cells (2)
  • streptavidin (1)
  • target genes (7)
  • tris (1)
  • v1 3 (1)
  • weak present (1)
  • white blood cell count (1)
  • x chromosomes (1)
  • β actin (2)
  • Sizes of these terms reflect their relevance to your search.

    Children with Down syndrome (DS) are at high risk of transient abnormal myelopoiesis (TAM) and myeloid leukemia of DS (ML-DS). GATA1 mutations are detected in almost all TAM and ML-DS samples, with exclusive expression of short GATA1 protein (GATA1s) lacking the N-terminal domain (NTD). However, it remains to be clarified how GATA1s is involved with both disorders. Here, we established the K562 GATA1s (K562-G1s) clones expressing only GATA1s by CRISPR/Cas9 genome editing. The K562-G1s clones expressed KIT at significantly higher levels compared to the wild type of K562 (K562-WT). Chromatin immunoprecipitation studies identified the GATA1-bound regulatory sites upstream of KIT in K562-WT, K562-G1s clones and two ML-DS cell lines; KPAM1 and CMK11-5. Sonication-based chromosome conformation capture (3C) assay demonstrated that in K562-WT, the - 87 kb enhancer region of KIT was proximal to the - 115 kb, - 109 kb and + 1 kb region, while in a K562-G1s clone, CMK11-5 and primary TAM cells, the - 87 kb region was more proximal to the KIT transcriptional start site. These results suggest that the NTD of GATA1 is essential for proper genomic conformation and regulation of KIT gene expression, and that perturbation of this function might be involved in the pathogenesis of TAM and ML-DS. © 2022. The Author(s).

    Citation

    Rika Kanezaki, Tsutomu Toki, Kiminori Terui, Tomohiko Sato, Akie Kobayashi, Ko Kudo, Takuya Kamio, Shinya Sasaki, Koji Kawaguchi, Kenichiro Watanabe, Etsuro Ito. Mechanism of KIT gene regulation by GATA1 lacking the N-terminal domain in Down syndrome-related myeloid disorders. Scientific reports. 2022 Nov 29;12(1):20587

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 36447001

    View Full Text